UNITEDHEALTH GROUP INC (UNH) Stock Analyst Earnings Estimates
NYSE:UNH - New York Stock Exchange, Inc. - US91324P1021 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 287.597B 11.84% | 324.162B 12.71% | 371.622B 14.64% | 404.98B 8.98% | 452.293B 11.68% | 486.031B 7.46% | 531.342B 9.32% | 570.115B 7.30% | 603.981B 5.94% | 640.959B 6.12% | 678.6B 5.87% | 718.618B 5.90% | |
| EBITDA YoY % growth | 27.073B 7.02% | 31.835B 17.59% | 36.33B 14.12% | 39.072B 7.55% | 43.04B 10.16% | 47.542B 10.46% | 51.302B 7.91% | 57.041B 11.19% | 62.466B 9.51% | 65.877B 5.46% | 69.49B 5.48% | 73.32B 5.51% | |
| EBIT YoY % growth | 23.97B 6.99% | 28.435B 18.63% | 32.358B 13.80% | 36.464B 12.69% | 39.064B 7.13% | 43.496B 11.35% | 47.374B 8.92% | 49.06B 3.56% | 53.955B 9.98% | 56.846B 5.36% | 59.927B 5.42% | 63.194B 5.45% | |
| Operating Margin | 8.33% | 8.77% | 8.71% | 9.00% | 8.64% | 8.95% | 8.92% | 8.61% | 8.93% | 8.87% | 8.83% | 8.79% | |
| EPS YoY % growth | 19.01 12.69% | 22.19 16.73% | 25.12 13.20% | 27.90 11.15% | 30.16 8.02% | 34.03 12.83% | 38.70 13.73% | 43.90 13.43% | 49.68 13.17% | 55.10 10.90% | 61.14 10.96% | 67.87 11.02% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.48 4.52% | 7.42 9.13% | 7.81 9.23% | 7.36 8.11% | 8.70 16.28% | 8.37 12.83% | 8.84 13.17% | 7.97 8.20% |
| Revenue Q2Q % growth | 107.639B 7.56% | 108.322B 9.33% | 109.251B 8.36% | 110.817B 9.93% | 116.496B 8.23% | 117.254B 8.25% | 117.932B 7.95% | 119.839B 8.14% |
| EBITDA Q2Q % growth | 10.721B 20.08% | 10.564B 6.79% | 11.131B -5.40% | 10.399B 5.35% | 11.988B 11.82% | 11.712B 10.87% | 12.595B 13.15% | 11.228B 7.97% |
| EBIT Q2Q % growth | 9.969B 25.70% | 9.616B 22.11% | 9.731B 11.75% | 9.611B 5.56% | 11.478B 15.14% | 11.144B 15.89% | 11.096B 14.03% | 10.424B 8.46% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 6.81 10.55% | 6.80 | 0.01 | 0.17% |
| Q3 2024 Q2Q % growth | 7.15 8.99% | 7.07 | 0.08 | 1.12% |
| Q2 2024 Q2Q % growth | 6.80 10.75% | 6.73 | 0.07 | 1.10% |
| Q1 2024 Q2Q % growth | 7.16 14.38% | 6.68 | 0.48 | 7.17% |
| Q4 2023 Q2Q % growth | 6.16 15.36% | 6.04 | 0.12 | 1.96% |
| Q3 2023 Q2Q % growth | 6.56 13.30% | 6.38 | 0.18 | 2.79% |
| Q2 2023 Q2Q % growth | 6.14 10.23% | 6.05 | 0.09 | 1.55% |
| Q1 2023 Q2Q % growth | 6.26 14.03% | 6.19 | 0.07 | 1.17% |
| Q4 2022 Q2Q % growth | 5.34 19.20% | 5.22 | 0.12 | 2.31% |
| Q3 2022 Q2Q % growth | 5.79 28.10% | 5.48 | 0.31 | 5.74% |
| Q2 2022 Q2Q % growth | 5.57 18.51% | 5.25 | 0.32 | 6.07% |
| Q1 2022 Q2Q % growth | 5.49 3.39% | 5.43 | 0.06 | 1.10% |
| Q4 2021 Q2Q % growth | 4.48 77.78% | 4.35 | 0.13 | 3.02% |
| Q3 2021 Q2Q % growth | 4.52 28.77% | 4.45 | 0.07 | 1.48% |
| Q2 2021 Q2Q % growth | 4.70 -33.99% | 4.48 | 0.22 | 4.95% |
| Q1 2021 Q2Q % growth | 5.31 42.74% | 4.43 | 0.88 | 19.95% |
| Q4 2020 Q2Q % growth | 2.52 -35.38% | 2.44 | 0.08 | 3.42% |
| Q3 2020 Q2Q % growth | 3.51 -9.54% | 3.12 | 0.39 | 12.37% |
| Q2 2020 Q2Q % growth | 7.12 97.78% | 5.33 | 1.79 | 33.60% |
| Q1 2020 Q2Q % growth | 3.72 -0.27% | 3.66 | 0.06 | 1.58% |
| Q4 2019 Q2Q % growth | 3.90 | 3.81 | 0.09 | 2.31% |
| Q3 2019 Q2Q % growth | 3.88 | 3.78 | 0.10 | 2.53% |
| Q2 2019 Q2Q % growth | 3.60 | 3.49 | 0.11 | 3.24% |
| Q1 2019 Q2Q % growth | 3.73 | 3.63 | 0.10 | 2.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 100.807B 6.76% | 102.683B | -1.876B | -1.83% |
| Q3 2024 Q2Q % growth | 100.82B 9.16% | 100.272B | 548M | 0.55% |
| Q2 2024 Q2Q % growth | 99.075B 6.64% | 99.824B | -749M | -0.75% |
| Q1 2024 Q2Q % growth | 100.075B 8.86% | 100.256B | -181M | -0.18% |
| Q4 2023 Q2Q % growth | 94.427B 14.06% | 93.085B | 1.342B | 1.44% |
| Q3 2023 Q2Q % growth | 92.361B 14.18% | 92.325B | 36M | 0.04% |
| Q2 2023 Q2Q % growth | 92.903B 15.65% | 91.917B | 986M | 1.07% |
| Q1 2023 Q2Q % growth | 91.931B 14.70% | 90.677B | 1.254B | 1.38% |
| Q4 2022 Q2Q % growth | 82.787B 12.26% | 83.416B | -629M | -0.75% |
| Q3 2022 Q2Q % growth | 80.894B 11.83% | 81.308B | -414M | -0.51% |
| Q2 2022 Q2Q % growth | 80.332B 12.63% | 80.48B | -148M | -0.18% |
| Q1 2022 Q2Q % growth | 80.149B 14.18% | 79.574B | 575M | 0.72% |
| Q4 2021 Q2Q % growth | 73.743B 12.64% | 73.476B | 267M | 0.36% |
| Q3 2021 Q2Q % growth | 72.337B 11.09% | 71.941B | 396M | 0.55% |
| Q2 2021 Q2Q % growth | 71.321B 14.78% | 70.17B | 1.151B | 1.64% |
| Q1 2021 Q2Q % growth | 70.196B 8.96% | 69.909B | 287M | 0.41% |
| Q4 2020 Q2Q % growth | 65.467B 7.50% | 65.713B | -246M | -0.37% |
| Q3 2020 Q2Q % growth | 65.115B 7.89% | 64.522B | 593M | 0.92% |
| Q2 2020 Q2Q % growth | 62.138B 2.55% | 64.131B | -1.993B | -3.11% |
| Q1 2020 Q2Q % growth | 64.421B 6.82% | 64.961B | -540M | -0.83% |
| Q4 2019 Q2Q % growth | 60.901B | 61.646B | -745M | -1.21% |
| Q3 2019 Q2Q % growth | 60.351B | 60.388B | -37M | -0.06% |
| Q2 2019 Q2Q % growth | 60.595B | 61.156B | -561M | -0.92% |
| Q1 2019 Q2Q % growth | 60.308B | 60.306B | 2M | 0.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.05% | 0% | -0.34% |
| Revenue | 0% | 0.89% | 0.01% | 0.4% |